Belmont, MA, United States of America

JoAnn Sekiguchi

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Sloan-Kettering Institute for Cancer Research, Invitrogen Corporation. Active years: 2003-2012.

USPTO Granted Patents = 3 

% Patents Active = 33.3

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2003-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Title: JoAnn Sekiguchi: Innovator in DNA and RNA Research

Introduction

JoAnn Sekiguchi is a prominent inventor based in Belmont, MA (US). She has made significant contributions to the field of molecular biology, particularly in the area of DNA and RNA interactions. With a total of 3 patents, her work has advanced our understanding of genetic material manipulation.

Latest Patents

JoAnn Sekiguchi's latest patents include innovative methods for covalently joining DNA strands to RNA strands using vaccinia topoisomerase. One of her inventions provides a method for tagging the 5' end of an RNA molecule and isolating full-length gene sequences using capped mRNA. Another patent details the formation of a topoisomerase-DNA intermediate, which allows for the ligation of DNA to RNA under specific conditions. These inventions have important implications for genetic research and biotechnology.

Career Highlights

Throughout her career, JoAnn has worked with esteemed organizations such as the Sloan-Kettering Institute for Cancer Research and Invitrogen Corporation. Her experience in these institutions has allowed her to collaborate with leading scientists and contribute to groundbreaking research in her field.

Collaborations

JoAnn Sekiguchi has collaborated with notable colleagues, including Stewart Shuman and Joseph M. Fernandez. These partnerships have further enriched her research and expanded the impact of her inventions.

Conclusion

JoAnn Sekiguchi's innovative work in DNA and RNA research has led to significant advancements in molecular biology. Her patents reflect her dedication to enhancing our understanding of genetic material and its applications in science and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…